TALK250117P7000
- 0.00
- 0.000.00%
Talkspace Newsroom
Analysts Conflicted on These Healthcare Names: Talkspace (TALK), Centene (CNC) and Alkermes (ALKS)
Talkspace Initiated at Overweight by Keybanc
KeyBanc Initiates Talkspace(TALK.US) With Buy Rating, Announces Target Price $4.5
Northland Securities Maintains Talkspace(TALK.US) With Buy Rating, Maintains Target Price $5
Talkspace Price Target Announced at $5.00/Share by Mizuho
Talkspace Initiated at Outperform by Mizuho
Northland Securities Initiates Talkspace(TALK.US) With Buy Rating, Announces Target Price $5
Talkspace Analyst Ratings
Northland Initiates Talkspace at Outperform With $5 Price Target
Talkspace Is Maintained at Equal-Weight by Barclays
Talkspace Analyst Ratings
TD Cowen Maintains Talkspace(TALK.US) With Buy Rating, Maintains Target Price $5
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Raises Target Price to $3
Needham Maintains Talkspace(TALK.US) With Hold Rating
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Maintains Target Price $2
Talkspace (TALK) Gets a Hold From Barclays
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Cuts Target Price to $2
TD Cowen Maintains Talkspace(TALK.US) With Buy Rating, Maintains Target Price $5
Talkspace Analyst Ratings
Needham Maintains Talkspace(TALK.US) With Hold Rating